LJPC logo

La Jolla Pharmaceutical (LJPC) CAPEX

Annual CAPEX

$9000.00
NaN%

December 31, 2021

Summary

Performance

1-Year Change

-

3-Year Change

-99.62%

5-Year Change

-99.9%

15-Year Change

-99.9%

LJPC CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$9.19 M
LJPC annual capital expenditures is currently -99.90% below its historical high of $9.19 million

3-Year Low

$9000.00
LJPC annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
LJPC previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
LJPC next annual earnings announcement has not yet been scheduled

OtherLJPCcash flowmetrics:

Annual FCF

$28.23 M
LJPC annual free cash flow is $28.23 million

Annual CFO

$28.24 M
LJPC annual cash flow from operations is $28.24 million

Annual CFI

-$9000.00
LJPC annual cash flow from investing activities is -$9000.00

Annual CFF

-$2.79 M
LJPC annual cash flow from financing activities is -$2.79 million

Quarterly CAPEX

N/A

June 30, 2022

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

LJPC Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$38.76 M
LJPC quarterly capital expenditures is currently at an all-time high

3-Year Low

$0.00
LJPC quarterly capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
LJPC previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
LJPC next earnings announcement has not yet been scheduled

OtherLJPCcash flowmetrics:

Quarterly FCF

$6.68 M
LJPC quarterly free cash flow is $6.68 million

Quarterly CFO

$6.68 M
LJPC quarterly cash flow from operations is $6.68 million

Quarterly CFI

$271.00 K
LJPC quarterly cash flow from investing activities is $271.00 thousand

Quarterly CFF

-$2.78 M
LJPC quarterly cash flow from financing activities is -$2.78 million

TTM CAPEX

N/A

June 30, 2022

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

LJPC TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$38.88 M
LJPC TTM capital expenditures is currently at an all-time high

3-Year Low

$9000.00
LJPC TTM capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
LJPC previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
LJPC next earnings announcement has not yet been scheduled

OtherLJPCcash flowmetrics:

TTM FCF

$13.12 M
LJPC TTM free cash flow is $13.12 million

TTM CFO

$13.13 M
LJPC TTM cash flow from operations is $13.13 million

TTM CFI

$262.00 K
LJPC TTM cash flow from investing activities is $262.00 thousand

TTM CFF

-$10.95 M
LJPC TTM cash flow from financing activities is -$10.95 million

LJPC CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years-99.6%--
5 y5 years-99.9%--

LJPC CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low
5 y5-year-98.7%at low
alltimeall time-99.9%at low

La Jolla Pharmaceutical CAPEX History

DateAnnualQuarterlyTTM
Dec 2021
$9000.00(-98.7%)
$0.00(-100.0%)
$9000.00(0.0%)
Sep 2021
-
$9000.00(-52.6%)
$9000.00(-98.7%)
Dec 2019
$698.00 K(-70.2%)
$19.00 K(-92.0%)
$698.00 K(-9.0%)
Sep 2019
-
$238.00 K(-7.4%)
$767.00 K(-14.8%)
Jun 2019
-
$257.00 K(+39.7%)
$900.00 K(-41.2%)
Mar 2019
-
$184.00 K(+109.1%)
$1.53 M(-34.6%)
Dec 2018
$2.34 M(-74.5%)
$88.00 K(-76.3%)
$2.34 M(-67.3%)
Sep 2018
-
$371.00 K(-58.2%)
$7.16 M(-20.9%)
Jun 2018
-
$887.00 K(-10.8%)
$9.05 M(-4.1%)
Mar 2018
-
$994.00 K(-79.7%)
$9.44 M(+2.7%)
Dec 2017
$9.19 M(+314.5%)
$4.91 M(+116.4%)
$9.19 M(+80.7%)
Sep 2017
-
$2.27 M(+78.4%)
$5.09 M(+52.8%)
Jun 2017
-
$1.27 M(+69.5%)
$3.33 M(+33.7%)
Mar 2017
-
$750.00 K(-6.1%)
$2.49 M(+12.3%)
Dec 2016
$2.22 M(+22.1%)
$799.00 K(+57.0%)
$2.22 M(+42.7%)
Sep 2016
-
$509.00 K(+17.8%)
$1.55 M(+10.9%)
Jun 2016
-
$432.00 K(-9.6%)
$1.40 M(-26.4%)
Mar 2016
-
$478.00 K(+254.1%)
$1.90 M(+4.8%)
Dec 2015
$1.82 M(+603.9%)
$135.00 K(-62.1%)
$1.82 M(-2.0%)
Sep 2015
-
$356.00 K(-61.9%)
$1.85 M(+21.3%)
Jun 2015
-
$934.00 K(+138.9%)
$1.53 M(+140.9%)
Mar 2015
-
$391.00 K(+127.3%)
$634.00 K(+145.7%)
Dec 2014
$258.00 K(+500.0%)
$172.00 K(+473.3%)
$258.00 K(+189.9%)
Sep 2014
-
$30.00 K(-26.8%)
$89.00 K(+45.9%)
Jun 2014
-
$41.00 K(+173.3%)
$61.00 K(+5.2%)
Mar 2014
-
$15.00 K(+400.0%)
$58.00 K(+34.9%)
Dec 2013
$43.00 K(+79.2%)
$3000.00(+50.0%)
$43.00 K(+7.5%)
Sep 2013
-
$2000.00(-94.7%)
$40.00 K(+5.3%)
Jun 2013
-
$38.00 K(-115.6%)
$38.00 K(>+9900.0%)
Jun 2011
-
-$243.00 K(-200.0%)
$0.00(-100.0%)
Mar 2011
-
$243.00 K(>+9900.0%)
$243.00 K(+912.5%)
Dec 2009
$24.00 K(-96.1%)
$0.00(0.0%)
$24.00 K(-85.2%)
Sep 2009
-
$0.00(-100.0%)
$162.00 K(+315.4%)
Jun 2009
-
$3000.00(-85.7%)
$39.00 K(-92.4%)
Mar 2009
-
$21.00 K(-84.8%)
$512.00 K(-17.7%)
Dec 2008
$622.00 K(-36.7%)
$138.00 K(-212.2%)
$622.00 K(-53.9%)
Sep 2008
-
-$123.00 K(-125.8%)
$1.35 M(-103.6%)
Jun 2008
-
$476.00 K(+263.4%)
-$37.37 M(-4202.0%)
Mar 2008
-
$131.00 K(-84.9%)
$911.00 K(-7.2%)
Dec 2007
$982.00 K(+193.1%)
$865.00 K(-102.2%)
$982.00 K(+622.1%)
Sep 2007
-
-$38.84 M(-200.2%)
$136.00 K(-99.7%)
Jun 2007
-
$38.76 M(>+9900.0%)
$38.88 M(>+9900.0%)
Mar 2007
-
$202.00 K(+963.2%)
$308.00 K(-8.1%)
Dec 2006
$335.00 K
$19.00 K(-118.8%)
$335.00 K(+5.7%)
Sep 2006
-
-$101.00 K(-153.7%)
$317.00 K(-28.1%)
DateAnnualQuarterlyTTM
Jun 2006
-
$188.00 K(-17.9%)
$441.00 K(+57.5%)
Mar 2006
-
$229.00 K(>+9900.0%)
$280.00 K(+127.6%)
Dec 2005
$123.00 K(-93.5%)
$1000.00(-95.7%)
$123.00 K(-76.4%)
Sep 2005
-
$23.00 K(-14.8%)
$521.00 K(-57.3%)
Jun 2005
-
$27.00 K(-62.5%)
$1.22 M(-26.3%)
Mar 2005
-
$72.00 K(-82.0%)
$1.66 M(-12.0%)
Dec 2004
$1.88 M(+4.0%)
$399.00 K(-44.7%)
$1.88 M(+8.1%)
Sep 2004
-
$722.00 K(+55.9%)
$1.74 M(+34.9%)
Jun 2004
-
$463.00 K(+55.4%)
$1.29 M(+15.7%)
Mar 2004
-
$298.00 K(+15.5%)
$1.12 M(-38.3%)
Dec 2003
$1.81 M(-64.8%)
$258.00 K(-5.1%)
$1.81 M(-46.3%)
Sep 2003
-
$272.00 K(-5.6%)
$3.37 M(-31.0%)
Jun 2003
-
$288.00 K(-70.9%)
$4.88 M(-9.5%)
Mar 2003
-
$991.00 K(-45.5%)
$5.40 M(+4.9%)
Dec 2002
$5.14 M(+283.5%)
$1.82 M(+1.8%)
$5.14 M(+39.0%)
Sep 2002
-
$1.79 M(+123.7%)
$3.70 M(+56.0%)
Jun 2002
-
$799.00 K(+8.3%)
$2.37 M(+23.6%)
Mar 2002
-
$738.00 K(+95.8%)
$1.92 M(+43.1%)
Dec 2001
$1.34 M(+147.9%)
$377.00 K(-17.7%)
$1.34 M(+4.0%)
Sep 2001
-
$458.00 K(+32.4%)
$1.29 M(+40.3%)
Jun 2001
-
$346.00 K(+116.3%)
$919.00 K(+48.2%)
Mar 2001
-
$160.00 K(-50.8%)
$620.00 K(+14.6%)
Dec 2000
$541.00 K(+200.6%)
$325.00 K(+269.3%)
$541.00 K(+36.6%)
Sep 2000
-
$88.00 K(+87.2%)
$396.00 K(+28.6%)
Jun 2000
-
$47.00 K(-42.0%)
$308.00 K(+91.3%)
Mar 2000
-
$81.00 K(-55.0%)
$161.00 K(-10.6%)
Dec 1999
$180.00 K(+80.0%)
$180.00 K(-280.0%)
$180.00 K(+80.0%)
Jun 1999
-
-$100.00 K(-200.0%)
$100.00 K(-200.0%)
Mar 1999
-
$100.00 K(0.0%)
-$100.00 K(-200.0%)
Dec 1998
$100.00 K(0.0%)
$100.00 K(-133.3%)
$100.00 K(0.0%)
Jun 1998
-
-$300.00 K(-200.0%)
$100.00 K(0.0%)
Mar 1998
-
$300.00 K(-250.0%)
$100.00 K(0.0%)
Dec 1997
$100.00 K(-50.0%)
-$200.00 K(-166.7%)
$100.00 K(-66.7%)
Sep 1997
-
$300.00 K(-200.0%)
$300.00 K(+200.0%)
Jun 1997
-
-$300.00 K(-200.0%)
$100.00 K(-80.0%)
Mar 1997
-
$300.00 K(>+9900.0%)
$500.00 K(+150.0%)
Dec 1996
$200.00 K(0.0%)
$0.00(-100.0%)
$200.00 K(-33.3%)
Sep 1996
-
$100.00 K(0.0%)
$300.00 K(+50.0%)
Jun 1996
-
$100.00 K(0.0%)
$200.00 K(0.0%)
Dec 1995
$200.00 K(-33.3%)
$100.00 K(>+9900.0%)
$200.00 K(>+9900.0%)
Sep 1995
-
$0.00(-100.0%)
$0.00(0.0%)
Jun 1995
-
$100.00 K(-200.0%)
$0.00(-100.0%)
Dec 1994
$300.00 K
-$100.00 K(<-9900.0%)
$300.00 K(-25.0%)
Sep 1994
-
$0.00(-100.0%)
$400.00 K(0.0%)
Jun 1994
-
$200.00 K(0.0%)
$400.00 K(+100.0%)
Mar 1994
-
$200.00 K
$200.00 K

FAQ

  • What is La Jolla Pharmaceutical annual capital expenditures?
  • What is the all time high annual CAPEX for La Jolla Pharmaceutical?
  • What is the all time high quarterly CAPEX for La Jolla Pharmaceutical?
  • What is the all time high TTM CAPEX for La Jolla Pharmaceutical?

What is La Jolla Pharmaceutical annual capital expenditures?

The current annual CAPEX of LJPC is $9000.00

What is the all time high annual CAPEX for La Jolla Pharmaceutical?

La Jolla Pharmaceutical all-time high annual capital expenditures is $9.19 M

What is the all time high quarterly CAPEX for La Jolla Pharmaceutical?

La Jolla Pharmaceutical all-time high quarterly capital expenditures is $38.76 M

What is the all time high TTM CAPEX for La Jolla Pharmaceutical?

La Jolla Pharmaceutical all-time high TTM capital expenditures is $38.88 M